NORGESTIMATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norgestimate, and what generic alternatives are available?
Norgestimate is a drug marketed by Glenmark Pharms Ltd, Glenmark Speclt, Lupin, Lupin Pharms, Mylan, Naari Pte, Watson Labs, and Xiromed. and is included in seventeen NDAs.
The generic ingredient in NORGESTIMATE is ethinyl estradiol; norgestimate. There are twenty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestimate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NORGESTIMATE?
- What are the global sales for NORGESTIMATE?
- What is Average Wholesale Price for NORGESTIMATE?
Summary for NORGESTIMATE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 17 |
| DailyMed Link: | NORGESTIMATE at DailyMed |
US Patents and Regulatory Information for NORGESTIMATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Pharms Ltd | NORGESTIMATE AND ETHINYL ESTRADIOL | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 200494-001 | Jun 17, 2011 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan | NORGESTIMATE AND ETHINYL ESTRADIOL | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 201896-001 | Jan 27, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lupin | NORGESTIMATE AND ETHINYL ESTRADIOL | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 205588-001 | Apr 26, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
